{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:19:31Z","timestamp":1773515971465,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.05.048","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T13:43:20Z","timestamp":1559569400000},"page":"5129-5135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Duration of immunity in recipients of two doses of 17DD yellow fever vaccine"],"prefix":"10.1016","volume":"37","member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2019.05.048_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre amarela [Yellow fever]","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2019.05.048_b0010","unstructured":"World Health Organization. International health regulations; 2005. Available at: http:\/\/www.who.int\/ihr\/9789241596664\/en\/index.html, http:\/\/www. who.int\/ith\/updates\/20140605\/en\/."},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.048_b0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev. Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.vaccine.2019.05.048_b0020","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigilancia em Saude. Guia de vigil\u00e2ncia epidemiol\u00f3gica. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigilancia em Saude. 6\u00aa ed. Brasilia: Minist\u00e9rio da Sa\u00fade; 2005. 816 p. (S\u00e9rie A. Normas e Manuais T\u00e9cnicos)."},{"key":"10.1016\/j.vaccine.2019.05.048_b0025","unstructured":"Calend\u00e1rio Nacional de Vacina\u00e7\u00e3o; 2017. http:\/\/portalms.saude.gov.br\/acoes-e-programas\/vacinacao\/calendario-nacional-de-vacinacao."},{"issue":"40","key":"10.1016\/j.vaccine.2019.05.048_b0030","first-page":"349","article-title":"WHO position paper","volume":"78","author":"World Health Organization Yellow fever vaccine","year":"2003","journal-title":"Wky Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.05.048_b0035","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper \u2013 June 2013","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wky Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.05.048_b0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"23","key":"10.1016\/j.vaccine.2019.05.048_b0045","first-page":"647","article-title":"Yellow fever vaccine booster doses: recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.05.048_b0050","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","author":"Collaborative Group for studies on yellow fever vacines","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.048_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.05.048_b0060","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigilancia em Saude. NOTA INFORMATIVA No 143\/CGPNI\/DEVIT\/SVS\/MS. http:\/\/www.saude.campinas.sp.gov.br\/doencas\/febre_amarela\/2016\/Nota-Informativa-143-Febre-Amarela-Site-A-a-Z-1.pdf."},{"key":"10.1016\/j.vaccine.2019.05.048_b0065","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigilancia em Saude. NOTA INFORMATIVA No 94, DE 2017\/CGPNI\/DEVIT\/SVS\/MS. http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2017\/novembro\/16\/Nota-Informativa-n94-Dose-unica-vacina-febre-amarela.pdf."},{"key":"10.1016\/j.vaccine.2019.05.048_b0070","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Programa Nacional de Imuniza\u00e7\u00e3o. Manual de Vigil\u00e2ncia Epidemiol\u00f3gica de Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o. 2\u00aa Edi\u00e7\u00e3o, Minist\u00e9rio da Sa\u00fade, Brasilia-DF, 2009."},{"key":"10.1016\/j.vaccine.2019.05.048_b0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.05.048_b0080","unstructured":"National Institute for Biological Standards and Control. WHO reference reagent. The 1st international reference preparation for anti-yellow fever serum monkey NIBSC code: YF. Available from: http:\/\/www.nibsc. ac.uk\/documents\/ifu\/YF.pdf; 2008."},{"key":"10.1016\/j.vaccine.2019.05.048_b0085","unstructured":"Nogueira RMR. Diagn\u00f3stico Laboratorial Espec\u00edfico e Diagn\u00f3stico Imunol\u00f3gico da Dengue. [Specific Laboratory Diagnosis and Immunodiagnosis of Dengue] \u2013 2nd Edition. Dengue Diagn\u00f3stico, Tratamento e Preven\u00e7\u00e3o [Dengue Diagnosis, Treatment and Prevention], Editora Rubio Ltda p. 97\u2013108]; 2008."},{"key":"10.1016\/j.vaccine.2019.05.048_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-5573-8-1","article-title":"WINPEPI updated: computer programs for epidemiologists, and their teaching potential","volume":"8","author":"Abramson","year":"2011","journal-title":"Epidemiol Perspect Innovations"},{"key":"10.1016\/j.vaccine.2019.05.048_b0095","unstructured":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects. 64th WMA General Assembly, Fortaleza, Brazil, October 2013. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/."},{"key":"10.1016\/j.vaccine.2019.05.048_b0100","unstructured":"Conselho Nacional de Sa\u00fade (Brasil). Resolu\u00e7\u00e3o No 466, 12 de dezembro de 2012. Bras\u00edlia. http:\/\/www.conselho.saude.gov.br\/web_comissoes\/conep\/index.html."},{"key":"10.1016\/j.vaccine.2019.05.048_b0105","article-title":"Secretaria de Estado de Sa\u00fade de Minas Gerais. Subsecretaria de Vigil\u00e2ncia e Prote\u00e7\u00e3o \u00e0 Sa\u00fade. Superintend\u00eancia de Vigil\u00e2ncia Epidemiol\u00f3gica, Ambiental e Sa\u00fade do Trabalhador","author":"Gerais","year":"2018","journal-title":"Boletim epidemiol\u00f3gico \u201305\/06\/2018"},{"key":"10.1016\/j.vaccine.2019.05.048_b0110","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 year(s) after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.048_b0115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2019.05.048_b0120","series-title":"Vaccines Ch. 37","article-title":"Measles vaccines","author":"Strebel","year":"2018"},{"key":"10.1016\/j.vaccine.2019.05.048_b0125","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/oxfordjournals.aje.a009952","article-title":"Measles epidemic in Romania, 1996\u20131998: assessment of vaccine effectiveness by case-control and cohort studies","volume":"150","author":"Hennessey","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"15","key":"10.1016\/j.vaccine.2019.05.048_b0130","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.048_b0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1963.12.230","article-title":"Wisseman Jr CL. Immunological studies withgroup B arthropod-borne viruses. IV: Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963","journal-title":"Am J Trop MedHyg"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.048_b0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.048_b0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"issue":"35","key":"10.1016\/j.vaccine.2019.05.048_b0150","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1016\/j.vaccine.2011.06.034","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.048_b0155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/14760584.2016.1198259","article-title":"Questions regarding the safety and duration of immunity following live yellow fever","volume":"15","author":"Amanna","year":"2016","journal-title":"Vaccin Exp Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:40Z","timestamp":1759401400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19306723"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of immunity in recipients of two doses of 17DD yellow fever vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}